Note: This article is informational and not a diagnostic tool. Self-checks on JobCannon are for personal awareness only, they cannot diagnose any condition. For a clinical assessment, consult a licensed healthcare professional.
You've been on ADHD medication for weeks or months, but focus, impulse control, or motivation hasn't improved as you expected. Do not stop or change your medicine on your own; talk to your prescribing clinician. This guide sets out what the NICE ADHD guideline, the UK prescribing information and the NHS say about the topics you may want to raise: your dose, when and how you take your medicine, your medication class, other conditions, and changes in your circumstances.
Reason 1: Discuss Whether Your Dose Is Too Low With Your Prescriber
Whether a dose is too low is for your prescriber to judge. NICE guideline NG87 says to titrate the dose against symptoms and adverse effects in line with the BNF or BNF for Children until dose optimisation is achieved, that is, reduced symptoms, positive behaviour change, improvements in education, employment and relationships, with tolerable adverse effects (recommendation 1.7.27, published 14 March 2018, last updated 13 September 2019, read 7 November 2026). Your prescriber sets the dose and the schedule; follow the leaflet that comes with your medicine.
The UK prescribing information prints a starting dose and a maximum for each medicine, not an average dose. For adults, the documents read on 7 November 2026 (emc, summaries of product characteristics) say:
- Methylphenidate: Concerta XL 18 mg prolonged-release tablets (date of revision of the text 06/11/2025): the recommended starting dose for adults who are not currently taking methylphenidate is 18 mg once daily, and the maximum daily dosage is 72 mg in adults.
- Lisdexamfetamine: Elvanse 30mg Hard Capsules (date of revision of the text 02/10/2026; the document covers children and adults and gives one starting dose and one maximum): the starting dose is 30 mg once daily in the morning, and the maximum recommended dose is 70 mg/day.
- Atomoxetine: Atomoxetine Glenmark 60 mg hard capsules (date of revision of the text 28/10/2024): the recommended maintenance daily dose is 80 mg to 100 mg, and the maximum recommended total daily dose is 100 mg.
The Elvanse 30mg Hard Capsules document also says that dosage should be individualised according to the therapeutic needs and response of the patient.
Next step: Review your dose history with your clinician. If you've been on the same dose for as long as your clinician advised and see no change, ask about a gradual increase, in steps and at intervals your clinician sets, until the dose is optimised, which NICE guideline NG87 describes as reduced symptoms with tolerable adverse effects (recommendation 1.7.27, published 14 March 2018, last updated 13 September 2019, read 7 November 2026). Your prescriber and the leaflet that comes with your medicine tell you which adverse effects to report. Ask your prescriber whether to keep a symptom diary of the date, your dose, and any change you notice in your focus, in getting started on tasks, or in impulse control.
Reason 2: Discuss Whether Your Dose Is Too High With Your Prescriber
Whether a dose is too high for you is for your prescriber to judge. For adults, the UK prescribing information for Elvanse lists anxiety, tremor, restlessness, feeling jittery, palpitation and tachycardia among the adverse reactions in the Common category (emc, Elvanse 30mg Hard Capsules, summary of product characteristics, date of revision of the text 02/10/2026, section 4.8, adults column of the table of adverse reactions, read 7 November 2026). Tell your prescriber about any of them; your prescriber decides whether they have to do with the dose.
Next step: Ask your clinician about a lower dose and when to reassess. Whether a lower dose suits you is for your prescriber to judge; NICE guideline NG87 says to monitor the effectiveness of medication for ADHD and its adverse effects (recommendation 1.8.1, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Reason 3: Discuss Your Medication Class With Your Prescriber
Whether your medication class suits you is for your prescriber to judge. NICE guideline NG87 says that, when prescribing stimulants for ADHD, prescribers should be aware that effect size, duration of effect and adverse effects vary from person to person (recommendation 1.7.21, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Next step: If you have been on one medicine for as long as your clinician advised and it has not helped enough, ask your prescriber whether a different medicine is an option. NICE guideline NG87 sets out when to consider switching between lisdexamfetamine and methylphenidate and when atomoxetine is offered to adults (recommendations 1.7.12, 1.7.13 and 1.7.15, published 14 March 2018, last updated 13 September 2019, read 7 November 2026); ask your prescriber which applies to you. Ask your prescriber how long to give a new medicine before it is reviewed.
Reason 4: Discuss When and How You Take Your Medicine With Your Prescriber
Whether to take a medicine with food, and when, differs by medicine and by brand, so follow the leaflet about food and drink and ask your prescriber if you take your medicine at different times. The UK prescribing information for Elvanse says it may be taken with or without food, and that food does not affect the observed AUC and Cmax of dexamfetamine in healthy adults after a single 70 mg dose but prolongs Tmax by approximately 1 hour (emc, Elvanse 30mg Hard Capsules, summary of product characteristics, date of revision of the text 02/10/2026, sections 4.2 and 5.2, read 7 November 2026). The UK prescribing information for Concerta XL says it is for oral use once daily in the morning and may be administered with or without food, and that in patients there were no differences in either the pharmacokinetics or the pharmacodynamic performance of Concerta XL when administered after a high fat breakfast on an empty stomach (emc, Concerta XL 18 mg prolonged-release tablets, summary of product characteristics, date of revision of the text 06/11/2025, sections 4.2 and 5.2, read 7 November 2026). The NHS page on how and when to take methylphenidate says that slow release tablets and capsules are usually taken in the morning, to check the leaflet for when to take it and whether to take it with food, and that Equasym XL is taken before breakfast while Medikinet XL is taken with or after breakfast (NHS, methylphenidate for adults, how and when to take it, page last reviewed 25 March 2025, read 7 November 2026). For methylphenidate, the NHS page for adults says that, apart from alcohol, there's no particular food or drink you need to be careful with (NHS, methylphenidate for adults, common questions, page last reviewed 25 March 2025, read 7 November 2026).
Next step: Follow the schedule your prescriber has set. Ask your clinician or pharmacist what the leaflet says about food and drink for your medicine. Ask your prescriber whether to keep a diary of timing and response, and for how long.
Reason 5: Discuss Coexisting Conditions With Your Prescriber
Whether another condition is affecting how your ADHD medicine works is for your prescriber to judge. NICE guideline NG87 says that, before starting medication for ADHD, people should have a full assessment that includes a review of mental health and social circumstances, including the presence of coexisting mental health and neurodevelopmental conditions, and a review of physical health (recommendation 1.7.4, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Next step: Tell your clinician about any anxiety, low mood, sleep problems or other health conditions you have. Ask your prescriber how a coexisting condition fits with your ADHD treatment. NICE guideline NG87 says to offer the same medication choices to people with ADHD and anxiety disorder, tic disorder or autism spectrum disorder as other people with ADHD (recommendation 1.7.18), and to make dose titration slower and monitoring more frequent if neurodevelopmental disorders, mental health conditions (for example anxiety disorders or depression) or physical health conditions (for example cardiac disease or epilepsy) are present (recommendation 1.7.28) (published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Reason 6: Discuss Changes in Your Circumstances With Your Prescriber
Whether changes in your circumstances are affecting how your ADHD medicine works is for your prescriber to judge. NICE guideline NG87 says that ADHD medication should be reviewed at least once a year, and that the review should include a comprehensive assessment of, among other things, the impact on education and employment, and the need for support and type of support (for example, psychological, educational, social) if medication has been optimised but ADHD symptoms continue to cause a significant impairment (recommendation 1.10.1, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Next step: Tell your prescriber about major changes in your work, home or health, and ask whether to keep the dose as it is and when to review it. Do not stop or change your medicine on your own. NICE guideline NG87 says to encourage people with ADHD to discuss any preferences to stop or change medication and to be involved in any decisions about stopping treatments (recommendation 1.10.2, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
Discuss Adding a Second Medicine With Your Prescriber
If you see some benefit on a single medicine but not full improvement, whether to add a second medicine is for your prescriber to decide. What NICE guideline NG87 says (published 14 March 2018, last updated 13 September 2019, read 7 November 2026):
- Do not offer any of the following medication for ADHD without advice from a tertiary ADHD service: guanfacine for adults (off-label use), clonidine for children with ADHD and sleep disturbance, rages or tics (off-label use), atypical antipsychotics in addition to stimulants for people with ADHD and coexisting pervasive aggression, rages or irritability, or medication not included in recommendations 1.7.7 to 1.7.15 (recommendation 1.7.17).
- Obtain a second opinion or refer to a tertiary service if ADHD symptoms are unresponsive to one or more stimulants and one non-stimulant (recommendation 1.7.16).
- Think about using a modified-release preparation of methylphenidate in the morning and an immediate-release preparation of methylphenidate at another time of the day to extend the duration of effect (recommendation 1.7.22).
Next step: If your medicine helps some but not enough, ask your prescribing clinician whether adding a second medicine is an option for you, and what the list above means for your situation.
Checklist of Things to Raise With Your Prescriber
Before you ask about switching medication: (1) Ask your clinician what dose you are on and what the leaflet that comes with your medicine says about the dose. (2) Ask your clinician how long you have been on that dose and how long to stay on it before the next review. (3) Ask your prescriber what to record about your adverse effects and response (NICE guideline NG87 says to encourage people taking medication for ADHD to monitor and record their adverse effects, for example by using an adverse effect checklist, recommendation 1.8.2, published 14 March 2018, last updated 13 September 2019, read 7 November 2026). (4) Ask your prescriber whether to keep a sleep diary (NICE guideline NG87 says to monitor changes in sleep pattern, for example with a sleep diary, and adjust medication accordingly, recommendation 1.8.17, published 14 March 2018, last updated 13 September 2019, read 7 November 2026). (5) Tell your clinician about any anxiety, low mood or other health conditions (NICE guideline NG87 says the yearly review of ADHD medication should include the effect of medication on existing or new mental health, physical health or neurodevelopmental conditions, recommendation 1.10.1, published 14 March 2018, last updated 13 September 2019, read 7 November 2026). (6) Tell your prescriber about major changes in your circumstances (see Reason 6). (7) Ask your prescriber about standard symptom and adverse effect rating scales (NICE guideline NG87 says to consider using them for clinical assessment and throughout the course of treatment, recommendation 1.8.3, published 14 March 2018, last updated 13 September 2019, read 7 November 2026).
On sleep (item 4 of the checklist): the NHS insomnia page says that everyone needs different amounts of sleep and that, on average, adults need 7 to 9 hours (NHS, Insomnia, page last reviewed 19 March 2024, read 7 November 2026).
Disclaimer
This article is educational only and not medical advice. If your ADHD medicine does not seem to help, talk to your prescribing clinician about it. Never stop or change medication without guidance.
Further Reading and Assessment
Ask your prescriber whether to note your symptoms before and after any dose change. Use the Focus & Energy Check-In as a personal record to bring to your reviews; like every self-check on JobCannon it is for personal awareness only and cannot diagnose any condition.
